BorfE2 |
Botch |
Hcc-1 |
||
This antineoplastic compound, known also as Velcade, is a dipeptide boronic acid formerly known as PS-341, LDP-341 and MLM341 (Adams and Kauffman, 2004). Bortezomib is a potent selective proteasome inhibitor of proteasome. Disruption of proteasome-mediated proteolysis of cellular proteins interferes with important cellular signaling and gene expression pathways and ultimately causes cell cycle arrest and cell death by apoptosis (Richardson et al, 2006; Schenkein, 2005).
The agent has been approved for the treatment of relapsed myeloma (San Miguel et al, 2006; Jackson et al, 2005) and may be suitable for treatment of other neoplastic cell types.
For other entries pertaining to
...
...
...
...
... Subscribe to continue reading!
... ...
Content view restricted ! |